BioGaia AB (publ) (BGLAF)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Peter Rothschild M.Sc. Econ., MBA | Founder & Chairman | 1.33M | -- | 1950 |
Ms. Theresa P. Agnew | CEO & President | 6.75M | -- | 1966 |
Mr. Alexander Kotsinas M.Sc. (Eng.). | Executive VP & CFO | 3.07M | -- | 1967 |
Ludvig Milesson | Chief Operating Officer | -- | -- | 1977 |
Mr. Gianfranco Grompone | Chief Scientific Officer and VP of Research & Development | -- | -- | 1975 |
Ms. Caroline Mofors | Chief Legal Officer | -- | -- | 1972 |
Ms. Linda Hagglund | Vice President of Marketing | -- | -- | 1973 |
Ms. Angelika Kjelldorff | Chief HR Officer | -- | -- | 1969 |
Sebastian Heimfors | VP & Chief Commercial Officer | -- | -- | 1974 |
Jonathan Gromark | Sustainability Manager | -- | -- | -- |
BioGaia AB (publ)
- Sector:?
- Healthcare
- Industry:? Drug Manufacturers - Specialty & Generic
- Full Time Employees:?
- 222
Description
BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.
Corporate Governance
Upcoming Events
October 22, 2024 at 6:00 AM UTC
BioGaia AB (publ) Earnings Date
Recent Events
May 8, 2024 at 12:00 AM UTC
Ex-Dividend Date